Exclusive: US FDA delays two drug reviews in new voucher program after safety, efficacy concerns - Reuters

Reuters | Jan. 15, 2026, 6:15 a.m. | Original
Exclusive: US FDA delays two drug reviews in new voucher program after safety, efficacy concerns Reuters
US farm economy shows widening cracks as costs rise, jobs vanish - Reuters US bond investors eye higher yields on Fed chair probe, threatening affordability - Reuters